Access keys

Skip to content Accessibility Home News, events and publications Site map Search Privacy policy Help Contact us Terms of use

Cutting-edge bioscience building opens to develop businesses

Copyright: Babraham Bioscience Technologies
  • Opening of The Bennet Building, housing sophisticated laboratories and office space for growing commercial life sciences enterprises
  • The Bennet Building is part of a £44M development programme for the Babraham Research Campus funded by the Biotechnology and Biological Sciences Research Council (BBSRC)

Cutting-edge molecular biology laboratories and office space for growing biotechnology businesses were formally opened today at the Babraham Research Campus, home to the BBSRC-supported Babraham Institute.

The Bennet Building was funded by BBSRC and is a flagship development in a £44M programme of public investment in the Babraham Research Campus.

World-leading bioscience research in the UK provides economic and social benefits within and beyond the UK. The Bennet building, constructed and managed by Babraham Bioscience Technologies (BBT) will further help develop and grow commercial life sciences enterprises by providing additional excellent facilities and support on the Babraham Research Campus.

The facility is already let to two tenants: Kymab, which develops new antibody medicines, and Eagle Genomics, providing bio-informatics services and management of Big Data.

The Bennet Building was officially opened by Dr Menelas Pangalos, Executive Vice President at Astra Zeneca.

Dr Celia Caulcott, BBSRC Executive Director for Innovation and Skills, said: "The UK is a world leader for bioscience research, making contributions here and around the world in areas such as health, food and energy production.

"The Bennet Building allows scientists working on developing bioscience businesses to stay close to the excellent academic work taking place at the Babraham Research Campus, whilst providing the best facilities and support to help their companies to thrive.

"I am delighted to see the Bennet Building open as part of a £44M BBSRC investment at the Babraham Research Campus."

Derek Jones, Babraham Bioscience Technologies Chief Executive, said: "With around sixty companies at the Babraham Research Campus, we continue to be an important regional centre for commercial life science research.

Co-location of world-class academic research carried out at the Babraham Institute, with early-stage and growing life science companies benefits both the academic science and the companies themselves, whether that is access to expertise and facilities, or the community that exists here."


Tags: bioeconomy commercialisation innovation policy BBSRC press release